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A comparative study of preservation solution was made in 
a 24 hour storaged donor lung between original UW 
(University of Wisconsin) solution (k = 120mEq/l) and 
Low potassium UW (k = 30mEq/l) solution. Preservation 
of a donor lung with low potassium UW solution was 
superior to that with original UW solution in terms of static 
compliance and pulmonary vascular resistance. 
 In conclusion, the use of low potassium UW solution is 
of great value to storage a donor lung.
Introduction 
In 1963, application of clinical lung transplantation was 
first reported by Hardy (1). Since Cooper et al (2) experi-
enced a long survival after lung transplantation, donor lung 
procurment has become a great item as in case of other 
organs. UW solution was developed by Belzer et al (3) in 
1983. The availability and validity of UW solution are 
clarly supported by many investigations concerning preser-
vation of the pancreas, kidney and liver. In contrast, preser-
vation of the lung is scant with the use of UW solution. 
 It is generally accepted that UW solution contains high 
concentration of potassium. The main drawback is that high 
potassium induces vasoconstriction to make increased vas-
cular resistance, by which ill-effect on function of a donor 
organ may be caused. 
 The purpose of this study is to clarify as to whether high 
potassium is required for a donor lung preservation or not.
pulmonary, artery, left atrium, extravascular water content, 
cardiac output, lung compliance, vascular resistance of the 
pulmonary artery. During the measurement, 500U/kg of 
heparin and 100ug/body of PGEI were intravenously giv-
en. A donor lung was flushed out with original UW solu-
tion (Group 1) and low potassium UW solution (Group 2) 
2) Preservation of a donor lung 
The heart and lung were en block removed and preserved 
with simple immersion at 4-8 °C of cold solution for 24 
hours. 
3) Estimation of viability of storaged lungs 
As shown in Fig. 1, the isolated lung perfusion model was 
used for assessment of viability of a 24 hour storaged 
donor lung. A donor lung was ventilated with air on the 
condition of 20m1/kg of tidal volume and 10/min of respi-
ratory retes. After 120 minutes of perfusion, the variance of
Material and Methods 
1) Donor preparation 
Mongrel dogs weighing 15 to 18kg were anesthetized with 
25mg/kg of pentobarbital sodium, intratracheally intubated 
and connected with Harvard respirator (10ml/kg of tidal 
volume). Midsternotomy was performed. Temporary occu-
sion of right main pulmonary artery and bronchus was 
made to measure arterial PO, and PCO2, the pressure of Fig. 1. Isolated Lung Perfusion Model
pulmonary hemodynamics were estimated in comparison in 
Group 1 (original UW solution) and Group 2 (low potas-
sium UW solution) between prior to and after lung preser-
vation for evaluation of superiority of low potassium UW 
solution to original UW one as a preservation solution.
Result 
The time durations of flushing, cold ischemia and warm 
ischemia were compared in storaged donor lungs as shown 
in Table 1. The flushing time in Group 1 was elongated as 
compared with that in Group 2. It reflected a result of 
vasoconstriction due to high concentration of potassium in 
original UW solution. The cold and warm ischemic times 
were almost the same between both two groups.
Fig. 3. Pulmonary Artery and Left Atrial Pressure
Table 1. Flushing, Cold Ischemic and Warm Ischemis Time of 
Graft Lungs
                     Group I Group II 
               (K'= l20mEq/L) (K+ = 30mEq/L)
Flushing time 257.0 ± 101.4sec 160.0 ± 67.5sec 
Cold ischemic time 24.1 ± 0.2hr 24.2 ± 0.3hr 
Warm ischemic time 75.0 ± 11.8min 61.9 ± 15.1min
  Fig. 2 revealed the results of changes in the aterial Pa02. 
The levels of Pa02 after perfusion were slightly declined in 
the both groups. There was not significant difference be-
tween both the groups. The pulmonary arterial (PAP) and 
left atrial pressures (LAP) were compared as shown in Fig. 
3. The PAP was increased in postperfusion although LAP 
remained almost constant. And PAP in postperfusion of 
Group 1 was kept high as compared with that in Group 2.
Fig. 4. Pulmonary Vascular Resistance
0.05). 
 The static and dynamic compliance were compared in 
both the groups between prior to and after perfusion as 
shown in Fig. 5, 6. These were reduced in Group 1 after 
perfusion, in particular, the statistic compliance was signifi-
cantly decreased (p < 0.05).
Fig. 2. PaO2
  Fig. 4 indicated changes in pulmonary vascular re-
sistance. It was apparent that original UW solution carried 
significant hazard of increased vascular resistance (p < Fig. 5. Static Compliance
Fig. 6. Dinamic Compliance
Discussion 
It is difficult to preserve a donor lung to maintaining an 
excellent function after transplantation because of vulner-
ability of lung parenchym to edema caused by high permi-
ability of pulmonary capillaries and alveoli. The maximum 
of lung preservation time is limited to be 3 to 4 hours at 
room temperature in inflated state. Since Blumenstock (4) 
first applied for cold preservation, cold storage has pre-
vailed for the purpose of suppression of oxygen demand in 
the field of various organ preservation and also preser-
vation solution was developed to prolonge the storage time 
with a mixture of various cytoprotective agents (5-7). The 
success in 24 hour preservation was reported by Crane et al 
(8) with Collins-Sack solution and the possibility of a 24 to 
72 hour preservation was suggested by Toledo-Pereyra et 
al (9) with modified silicagel fraction in animals. However, 
a 6-8 hour preservation is now ensured in clinical use. 
Therefore, development of better solution is desired for 
prelongation of a safety limit of lung preservation. Eeuro-
Collins (EC) solution has been widely used for organ 
preservation prior to development of UW solution. How-
ever, since UW solution was recenlty developed as a 
solution similar to the composition of intracellular fluid, 
UW solution has been regarded as the best preservation 
solution in the kidney, pancreas and liver. Reports are now 
scant concerning lung preservation with respect to UW 
solution. It is defined that UW solution is characteristic in 
that (1) lactobionate inhibits enlargement of cells (2) phos-
phate plays a role in prevention of intracellular acidosis as
buffer to hydrogen (3) hydroxyl starch serves as harmless 
colloid to avoid occurring edema (4) glutathion and allo-
prinol act as antagonist of oxygen free radical generated 
during ischemia. In fact, many investigators clarified the 
mechanisim of reperfusion injury. Prevention of reper-
fusion injury is the most important to succeed in prolonged 
lung preservation. It is well known that active oxygen plays 
an important role in reperfusion injury (10) and also cal-
cium overload at the time of reperfusion is a cause of 
reperfusion which is termed as calcium paradox phenom-
enon (11). Recent studies (12) reported that UW solution 
with extracellular fluid composition was more effective 
than other solutions similar to intracellular fluid compo-
sition in making it possible to prolonge the preservation 
time. In this study, low potassium content of UW solution 
was superior to original one in evaluation of a preserved 
donor lung function. 
  In conclution, it is emphasized that low potassium UW 
solution is of great value in clinical use
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